Siltuximab Treatment: Uses, Dosage & Side Effects Guide

Key Points About Siltuximab Treatment

Siltuximab is a prescription medication primarily used to treat rare conditions such as Multicentric Castleman disease and certain types of cancer. This anti-IL-6 monoclonal antibody works by inhibiting a protein in the body that contributes to inflammation and abnormal cell growth. Siltuximab is administered through intravenous (IV) infusion, typically in a healthcare setting under the supervision of a medical professional. Always consult your healthcare provider before starting or making any changes to your medication regimen, including Siltuximab.

Medication Names and Classification

US Brand Name: Sylvant (Siltuximab)

The generic name, Siltuximab, refers to the active ingredient in the medication, while Sylvant is the brand name assigned by the manufacturer.

Pharmacologic Category

1. Monoclonal Antibody
2. Interleukin-6 (IL-6) Inhibitor

Siltuximab Dosage Guidelines

The appropriate dosage of Siltuximab depends on the specific condition being treated. It is essential to follow your healthcare provider’s instructions carefully and avoid altering your dose without medical guidance. If you have any questions about your prescribed dosage, consider scheduling a consultation with your healthcare provider, either in person or via telemedicine.

Dosage for Multicentric Castleman Disease (MCD)

1. Recommended Dose: 11 mg/kg
2. Frequency: Every 3 weeks
3. Length of Treatment: Ongoing, as determined by your healthcare provider

Dosage for Non-Hodgkin Lymphoma

1. Recommended Dose: 11 mg/kg
2. Frequency: Every 3 weeks
3. Length of Treatment: Based on your response to treatment and your doctor’s recommendation

Dosage for Kaposi’s Sarcoma (Including HIV-Associated)

1. Recommended Dose: 11 mg/kg
2. Frequency: Every 3 weeks
3. Length of Treatment: As directed by your healthcare provider

Other Conditions Treated with Siltuximab

1. Castleman Disease: 11 mg/kg every 3 weeks
2. Lymphoproliferative Disorders: 11 mg/kg every 3 weeks
3. Systemic Lupus Erythematosus: Consult your healthcare provider for specific dosing
4. Rheumatoid Arthritis: Consult your healthcare provider for specific dosing
5. Sarcoidosis: Consult your healthcare provider for specific dosing
6. Graft-Versus-Host Disease: Consult your healthcare provider for specific dosing

Available Dosage Forms and Strengths

1. Injection: 100 mg/5 mL (20 mg/mL) solution in a single-dose vial
2. Injection: 400 mg/20 mL (20 mg/mL) solution in a single-dose vial

Siltuximab Administration Guidelines

Siltuximab is administered as an intravenous (IV) infusion, delivered directly into a vein by a trained healthcare professional. Each infusion typically takes about one hour. Patients are required to visit a healthcare facility for every dose. It is important to attend all scheduled appointments to ensure the medication’s effectiveness. If you miss a dose, contact your healthcare provider as soon as possible to reschedule.

Potential Side Effects of Siltuximab

As with any medication, Siltuximab may cause side effects. While some are mild and relatively common, others can be more serious but occur less frequently. If you experience any side effects, notify your healthcare provider immediately. You may also consider scheduling a telemedicine appointment to discuss your symptoms and concerns.

Common Side Effects of Siltuximab

1. Fatigue: Feeling unusually tired or weak
2. Nausea: A sensation of sickness or discomfort in the stomach
3. Upper Respiratory Infections: Symptoms such as cough, sore throat, or nasal congestion
4. Rash: Red, itchy, or irritated skin

Serious Side Effects of Siltuximab

1. Severe Allergic Reactions: Swelling of the face, lips, tongue, or throat; difficulty breathing
2. Infections: Symptoms such as fever, chills, or other signs of infection
3. Liver Problems: Yellowing of the skin or eyes, dark-colored urine
4. Low Blood Cell Counts: Increased risk of infections, bruising, or bleeding

Contraindications of Siltuximab

A contraindication refers to a specific condition or circumstance in which a medication, such as Siltuximab, should not be used because it may pose significant risks to the patient. Understanding these contraindications is crucial to prevent serious side effects or complications during treatment with Siltuximab.

Siltuximab is contraindicated in the following situations:

Severe infections: Siltuximab can suppress certain components of the immune system, which may impair the body’s ability to fight infections effectively. If you have a severe infection, using Siltuximab could exacerbate your condition and delay recovery.

Hypersensitivity to Siltuximab: Patients who have experienced an allergic reaction to Siltuximab or any of its ingredients should avoid this medication. Allergic reactions can vary in severity, ranging from mild symptoms like rash or itching to severe, potentially life-threatening reactions such as anaphylaxis.

HIV, HHV-8, or Hepatitis B infection: Siltuximab is not recommended for individuals with these viral infections. The medication may interfere with the body’s ability to manage these viruses, potentially leading to a worsening of the infection or other complications.

Drug-to-Drug Interactions with Siltuximab

When undergoing treatment with Siltuximab, it is essential to inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medications, vitamins, and dietary supplements. Siltuximab may interact with certain medications, which can increase the likelihood of side effects or reduce the effectiveness of your treatment.

Some medications that may interact with Siltuximab include:

1. Warfarin (Coumadin): Siltuximab may influence how your body metabolizes blood thinners like warfarin, potentially increasing the risk of bleeding complications.
2. Cyclosporine (Neoral, Gengraf, Sandimmune): This immunosuppressive medication may interact with Siltuximab, heightening the risk of infections or other immune-related issues.
3. Statins (e.g., Atorvastatin [Lipitor]): Siltuximab may alter the metabolism of statins, which are used to manage cholesterol levels. This interaction could increase the risk of side effects such as muscle damage or liver problems.
4. Vaccines: Live vaccines, such as the measles, mumps, and rubella (MMR) vaccine, should not be administered during Siltuximab treatment. The medication may weaken the immune system’s response to these vaccines, reducing their effectiveness.

Siltuximab and Pregnancy

Is it safe to take Siltuximab during pregnancy?

There is limited information available regarding the safety of Siltuximab use during pregnancy. Animal studies have indicated potential risks to the developing fetus, but no well-controlled studies have been conducted in pregnant women. As a result, Siltuximab should only be used during pregnancy if the potential benefits clearly outweigh the risks. If you are pregnant or planning to become pregnant, it is important to consult your healthcare provider to determine the most appropriate course of action. For personalized advice, you may also connect with one of our providers through telemedicine.

Siltuximab and Breastfeeding

Is it safe to take Siltuximab while breastfeeding?

It is currently unknown whether Siltuximab passes into breast milk. Due to the lack of available data and the potential for serious side effects in a nursing infant, breastfeeding is generally not recommended while undergoing treatment with Siltuximab. If you are breastfeeding or planning to breastfeed, discuss the potential risks and benefits with your healthcare provider. For further guidance, you can also consult one of our providers through telemedicine.

Estimated Cost of Siltuximab Medication

The cost of Siltuximab can vary significantly depending on your location and the pharmacy you use. Without insurance, the price for a 30-day supply typically ranges between $10,000 and $15,000 when using a GoodRx coupon. For the most accurate and up-to-date pricing, it’s best to consult your local pharmacy directly. If affordability is a concern, consider exploring financial assistance programs, which may help reduce the financial burden of treatment.

Possible Alternatives to Siltuximab Treatment

If Siltuximab is not the right option for you, there are alternative treatments available for the conditions it is designed to address. It’s essential to consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to discuss your options in detail.

Alternative Treatments for Multicentric Castleman Disease

Other treatment options include immunosuppressive therapies such as Rituximab (Rituxan) or corticosteroids. In certain cases, chemotherapy may also be considered as part of the treatment strategy.

Alternative Treatments for Non-Hodgkin Lymphoma

Non-Hodgkin lymphoma can be treated with chemotherapy, radiation therapy, or targeted therapies like Rituximab (Rituxan) and Ibrutinib (Imbruvica). Your healthcare provider will determine the most appropriate approach based on your specific diagnosis and overall health.

Alternative Treatments for Kaposi’s Sarcoma

Treatment options for Kaposi’s sarcoma may include antiretroviral therapy (particularly for HIV-associated cases), chemotherapy, or radiation therapy. The choice of treatment depends on the severity and progression of the disease.

Alternative Treatments for HIV-Associated Kaposi’s Sarcoma

For HIV-associated Kaposi’s sarcoma, antiretroviral therapy (ART) is the cornerstone of treatment. In some cases, ART may be supplemented with chemotherapy or radiation therapy to manage more advanced or resistant cases.

Alternative Treatments for Castleman Disease

In addition to Siltuximab, other treatment options for Castleman disease include Rituximab (Rituxan), corticosteroids, or chemotherapy. The choice of therapy depends on the type and severity of the disease.

Alternative Treatments for Lymphoproliferative Disorders

Treatment for lymphoproliferative disorders varies based on the specific condition but may involve chemotherapy, immunotherapy, or stem cell transplantation. Your healthcare provider will tailor the treatment plan to your individual needs.

Alternative Treatments for Systemic Lupus Erythematosus

Common treatments for systemic lupus erythematosus include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, antimalarials like Hydroxychloroquine (Plaquenil), and immunosuppressive medications. These therapies aim to manage symptoms and prevent disease flares.

Alternative Treatments for Rheumatoid Arthritis

For rheumatoid arthritis, alternatives include disease-modifying antirheumatic drugs (DMARDs) such as Methotrexate, biologic therapies like Adalimumab (Humira), and lifestyle modifications such as physical therapy and regular exercise. These approaches work together to reduce inflammation and improve joint function.

Alternative Treatments for Sarcoidosis

Sarcoidosis treatment options may include corticosteroids, immunosuppressive medications, or antimalarials like Hydroxychloroquine (Plaquenil). The choice of therapy depends on the organs affected and the severity of the condition.

Alternative Treatments for Graft-Versus-Host Disease

For graft-versus-host disease, treatment options include corticosteroids, immunosuppressive drugs, and biologic therapies such as Ruxolitinib (Jakafi). These treatments aim to control the immune response and reduce symptoms.

Recent Updates on Siltuximab Research

Recent research on Siltuximab has focused on its potential to treat additional inflammatory and immune-related conditions. For example, ongoing studies are evaluating its role in managing cytokine storms associated with severe cases of COVID-19. While early findings have been mixed, researchers continue to investigate its safety and effectiveness in this context.

Additionally, scientists are exploring Siltuximab’s potential applications in other cancers and autoimmune diseases, such as multiple myeloma and rheumatoid arthritis. Although these studies are still in their early stages, they offer promising insights into expanding the use of Siltuximab to address a broader range of medical conditions. If you’re interested in learning more about these developments or participating in clinical trials, consult your healthcare provider or schedule a telemedicine consultation with one of our specialists.

James Kingsley

Learn More